Dubai is fast emerging as a hub for the global longevity movement, and Ankiti Bose, founder of Dubai-based investment firm Terra Invest, believes humans could soon live to 150 if they maintain their health.

“Longevity is one of humanity’s greatest achievements, but also our biggest failure,” Bose says. “We’ve doubled lifespan, not health span.” Through a major stake in Shookra Aesthetics, a chain of AI-driven longevity clinics, Terra Invest is betting on a new model of healthcare that combines preventive medicine, regenerative science, and medical aesthetics.

Shookra clinics operate like a hybrid of a lab and luxury wellness center. Patients undergo comprehensive scans like DNA sequencing, blood-age testing, hormonal analysis, and AI-based facial imaging to create personalized “longevity maps.” Treatments range from NAD+ IV drips and stem-cell therapy to aesthetic procedures designed to improve overall cellular health.

“Beauty is simply biology made visible,” Bose explains. “When your skin is healthy, it reflects your inner health.” For Terra Invest, the model bridges two booming markets: medical aesthetics, projected at $70 billion globally, and longevity, estimated to reach $600 billion by 2030. “They are two faces of the same idea: human optimization,” Bose adds.

Dubai provides fertile ground for this experiment. With a government focus on biotech and AI, alongside a growing affluent population, the UAE has become a $4 billion medical-tourism market. Shookra’s first clinic opened in Business Bay this year, with more locations under construction in Abu Dhabi and Palm Jumeirah, and expansion plans for Riyadh, Singapore, and London.

Studies show delaying aging even slightly could drastically reduce age-related deaths. Extending healthy life expectancy by just one year could create $38 trillion in global welfare value. “Medicine has traditionally waited for people to break,” Bose says. “We want medicine that keeps you unbreakable.”

While skeptics warn that many regenerative therapies are still experimental, Bose emphasizes rigorous oversight and peer-reviewed research. “We’re not chasing immortality; we are professionalizing vitality.”

For Bose, the implications go beyond business. “If we can prevent suffering, we have a duty to,” she says. “Imagine the last 20 years of life being as active as the first 50. That’s what’s at stake.” She believes.